Orrick Herrington & Sutcliffe LLP advised Third Rock Ventures and Lightspeed Venture on the deal.Abata Therapeutics has launched with $95 million in series A funding to…
Abata Therapeutics’ $95 million Series A Financing Round


Orrick Herrington & Sutcliffe LLP advised Third Rock Ventures and Lightspeed Venture on the deal.Abata Therapeutics has launched with $95 million in series A funding to…
…